晶升股份(688478.SH):實際控制人兼董事長李輝擬增持1000萬元-2000萬元公司股份
格隆匯4月10日丨晶升股份(688478.SH)公佈,公司控股股東、實際控制人兼董事長李輝先生擬使用其自有資金或自籌資金,自2025年4月11日起6個月內,通過上海證券交易所交易系統允許的方式(包括但不限於集中競價和大宗交易等)增持公司股份,合計增持金額不低於人民幣1000萬元(含)且不超過人民幣2000萬元(含)。本次增持股份計劃不設價格區間,將根據公司股票的價格波動情況及資本市場整體態勢擇機實施增持計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.